Director/Officer Tony Thene Files to Sell $27.8M in Carpenter Technology Stock
CRS has more than doubled off its 52-week low of $228.
Summary
Carpenter Technology director and officer Tony Thene filed to sell 57,456 shares valued at approximately $27.8 million, sourced from 2025 performance and restricted stock grants.
Key Events · Ownership and Investor Activity · CRS
-
Insider Sale Filing
A Form 144 was filed by Tony R. Thene, a director and officer, to sell 57,456 shares valued at approximately $27.8 million.
-
Share Source
The shares were acquired through performance shares (19,000 and 38,100 shares) and restricted stock (356 shares) granted in July-August 2025.
-
No Recent Sales
With no sales reported in the past three months, this filing marks a notable new liquidity event for the filer.
-
Context
The sale follows record FY26 results and a new $1 billion buyback authorization announced on August 12, 2026.
Analysis · CRS · Manufacturing
A Form 144 filed by Tony R. Thene, a director and officer of Carpenter Technology, discloses plans to sell 57,456 shares worth approximately $27.8 million. The shares stem from performance share and restricted stock grants received in mid-2025. This insider sale is significant, particularly against the backdrop of the company's recent record results and a $1 billion buyback authorization. While the transaction represents a substantial personal liquidity event for Thene, it does not necessarily indicate a negative view of the company's fundamentals.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 29.6% of the 2856 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRS was trading at $486.09 on NYSE in the Manufacturing sector, with a market capitalization of approximately $24.1B. The 52-week trading range was $228.00 to $625.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.